Ryan Liabenow has over 15 years of experience in the healthcare consulting and management industry, with a diverse background in managed care and healthcare distribution channels.
The economic and professional appeal of DPC has caused it to spread to at least 24 states. Scalable models are being developed and increasingly attract investor dollars.
While certain key generic drugs will take billions in drug costs out of the healthcare system in the next 3 to 4 years, this anticipated decline in spending is masking the growth of specialty drug costs.